Yahoo Finance • 11 months ago
Key Insights Institutions' substantial holdings in Heron Therapeutics implies that they have significant influence over the company's share price The top 9 shareholders own 53% of the company Insiders have bought recently A look at the s... Full story
Yahoo Finance • last year
Heron is increasing full-year 2023 Net Product Sales guidance for the oncology care franchise to a range of $104 million to $106 million from a prior range of $99 million to $103 million We anticipate full-year 2023 Net Product Sales to be... Full story
Yahoo Finance • 2 years ago
Shares of Heron Therapeutics (NASDAQ: HRTX) stormed higher by 47% over the first 3 1/2 days of trading this week, according to data provided by S&P Global Market Intelligence. The big gain came in response to the appointment of Craig Colla... Full story
Yahoo Finance • 2 years ago
SAN DIEGO, March 13, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most impor... Full story
Yahoo Finance • 2 years ago
In this article, we discuss 12 best affordable stocks to buy under $5. If you want to see more stocks in this selection, check out 5 Best Affordable Stocks to Buy Under $5. Third Point, a New York-based financial advisor, published its th... Full story
Yahoo Finance • 2 years ago
Heron Therapeutics Inc. said Thursday it will lay off about one-third of its workforce as part of a restructuring expected to save $43 million a year. The biotechnology company's stock was still inactive in premarket trading. The company s... Full story
Yahoo Finance • 3 years ago
In this article, we discuss the 10 most shorted stocks to watch today. To take a look at some more stocks, go directly to the 5 Most Shorted Stocks to Watch. The US stock market has been in a correction mode as the S&P 500 Index and the D... Full story